Protective effect of non-mitogenetic human acidic fibroblast growth factor against myocardial ischemia-reperfusion injury in rats

Hua Xu,Xiaokun Li,HUANG Ya-dong,Qing Zheng,Zhijian Su,WU Xiao-ping,ZHAO Zhuan-you
DOI: https://doi.org/10.3321/j.issn:1000-5048.2009.02.014
2009-01-01
Abstract:Aim:To investigate the protective effect of non-mitogenetic human acidic fibroblast growth factor(nmhaFGF) against myocardial ischemia-reperfusion injury in rats.Methods:Myocardial ischemia-reperfusion injury was induced by 30-minute occlusion of left anterior descending coronary artery (LADCA) followed by 3-hr reperfusion.Viable doses of nmhaFGF were infused intravenously at 20 minutes after LADCA occlusion.The incidence and latency phase and duration of ventricular tachycardia (VT) and ventricular fibrillation (VF) were monitored,and the fraction of arrhythmia was reckoned;myocardial infarct area,the serum aspartate aminotransferase (AST)and lactate dehydrogenase (LDH) and MB isoenzyme of creatine kinase (CK-MB) content were detected at 24 hours after reperfusion.Results:Results showed that nmhaFGF (20,40,80 μg/kg) could relieve myocardial injury induced by ischemia-reperfusion.Compared to the model group,mmhaFGF of the selected doses was responsible for the decreased incidences in VT and VF,the delayed latency,the shortened duration and the reduced fraction of arrhythmia.In addition,the percentages of the infarct area relative to the total area of the left ventricle and the percentage of the infarct area relative to area at risk markedly decreased.Moreover,there were dramatically decreases in AST and LDH and CK-MB contents in nmhaFGF groups there was no statistical difference between nmhaFGF 80 μg/kg group and propranolol 8 mg/kg group.Conclusion:nmhaFGF could protect the myocardium against the damages induced by ischemia-reperfusion in rats.
What problem does this paper attempt to address?